26 May 2013
Keywords: schering, ag, starts, trial, compare, betaferon, copaxone
Article | 08 July 2002
Schering AG of Germany has announced the initiation of the BEYOND(Betaseron Efficacy Yielding Outcomes of a New Dose) study, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 July 2002
24 May 2013
© 2013 thepharmaletter.com